Novamed

Company Overview

Snapshot

Founded in December 1995, Novamed operates with 11–50 employees. The company was acquired by Simplivia Healthcare in January 2021, marking a significant milestone in its journey.

Business overview

Novamed develops proprietary diagnostic systems for the rapid detection of microorganisms and for urinalysis. Its core products include FDA-approved culture devices like DipStreak and Diaslide for urinary tract infections, NovaStreak for food and dairy product testing, and NovaCup, an innovative urine collection cup with an integrated urinalysis testing strip. The company serves the health tech and life sciences sectors, providing solutions for point-of-care, home users, and laboratories.

Strategic signal

In January 2021, Novamed was acquired by Simplivia Healthcare, indicating a strategic consolidation within the health tech and life sciences sector. This acquisition suggests a validation of Novamed's diagnostic technologies and provides Simplivia Healthcare with an expanded portfolio in rapid diagnostic solutions, particularly for home and point-of-care applications.

Company Intelligence Q&A

What is NovaCup?

NovaCup is an innovative urine collection cup developed by Novamed that features an integrated full-panel urinalysis testing strip. It provides quantifiable results for point-of-care or home users without requiring urine samples to be sent to a laboratory.

Which diagnostic systems has Novamed developed?

Novamed has developed several proprietary diagnostic systems, including the FDA-approved DipStreak and Diaslide culture devices for rapid diagnosis of urinary tract infections, and NovaStreak for detecting microorganisms in food and dairy products.

When was Novamed acquired?

Novamed was acquired by Simplivia Healthcare in January 2021.

What was Novamed's involvement in COVID-19 testing?

In March 2020, Novamed partnered with BATM to develop a COVID-19 home rapid test kit. Additionally, in October 2020, UHWI researched COVID-19 pool-testing in partnership with Novamed.

What is SensAheart?

SensAheart is a device developed by Novamed that can test for heart attacks before they happen, as reported in February 2018.